SEC Comment Letter 0000000000-23-003395 to Privia Health Group, Inc. (PRVA) (CIK 0001759655) (PRVA)
Privia Health Group, Inc. (PRVA) (CIK 0001759655)
Date: April 4, 2023 · CIK: 0001759655 · Accession: 0000000000-23-003395
AI Filing Summary & Sentiment
File numbers found in text: 001-40365
Letter
United States securities and exchange commission logo April 4, 2023 Shawn Morris Chief Executive Officer Privia Health Group, Inc. 950 N. Glebe Road, Suite 700 Arlington, Virginia 22203 Re:Privia Health Group, Inc. Form 10-K for the Fiscal Year Ended December 31, 2022 Filed March 1, 2023 File No. 001-40365 Dear Shawn Morris : We have limited our review of your filing to the financial statements and related disclosures and have the following comment. In our comment, we may ask you to provide us with information so we may better understand your disclosure. Please respond to the comment within ten business days by providing the requested information or advise us as soon as possible when you will respond. If you do not believe our comment applies to your facts and circumstances, please tell us why in your response. After reviewing your response to the comment, we may have additional comments. Form 10-K for the Fiscal Year Ended December 31, 2022 Key Metrics and Non-GAAP Financial Measures, page 72 1.In future filings, please revise to reconcile the non-GAAP measures "Care Margin" and "Platform Contribution" to the most comparable GAAP measure, which appears to be Gross Profit, even if it is not presented on the face of the Statements of Operations. Please also revise the similar reconciliation in Exhibit 99.1 to your Form 8-K dated February 28, 2023.
FirstName LastNameShawn Morris Comapany NamePrivia Health Group, Inc. April 4, 2023 Page 2 FirstName LastName Shawn Morris Privia Health Group, Inc. April 4, 2023 Page 2 In closing, we remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. You may contact Christie Wong at (202) 551-3684 or Julie Sherman at (202) 551- 3640 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services
Show Raw Text
United States securities and exchange commission logo
April 4, 2023
Shawn Morris
Chief Executive Officer
Privia Health Group, Inc.
950 N. Glebe Road, Suite 700
Arlington, Virginia 22203
Re:Privia Health Group, Inc.
Form 10-K for the Fiscal Year Ended December 31, 2022
Filed March 1, 2023
File No. 001-40365
Dear Shawn Morris :
We have limited our review of your filing to the financial statements and related
disclosures and have the following comment. In our comment, we may ask you to provide us
with information so we may better understand your disclosure.
Please respond to the comment within ten business days by providing the requested
information or advise us as soon as possible when you will respond. If you do not believe our
comment applies to your facts and circumstances, please tell us why in your response.
After reviewing your response to the comment, we may have additional comments.
Form 10-K for the Fiscal Year Ended December 31, 2022
Key Metrics and Non-GAAP Financial Measures, page 72
1.In future filings, please revise to reconcile the non-GAAP measures "Care Margin" and
"Platform Contribution" to the most comparable GAAP measure, which appears to
be Gross Profit, even if it is not presented on the face of the Statements of Operations.
Please also revise the similar reconciliation in Exhibit 99.1 to your Form 8-K dated
February 28, 2023.
FirstName LastNameShawn Morris
Comapany NamePrivia Health Group, Inc.
April 4, 2023 Page 2
FirstName LastName
Shawn Morris
Privia Health Group, Inc.
April 4, 2023
Page 2
In closing, we remind you that the company and its management are responsible for the
accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or
absence of action by the staff.
You may contact Christie Wong at (202) 551-3684 or Julie Sherman at (202) 551-
3640 with any questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services